Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		Phase III Randomized Study of Radiotherapy Combined With Temozolomide Versus Carmustine in Patients With Anaplastic Astrocytoma or Mixed Gliomas

		Phase:		Phase 3

		Treatment ID#:		1093 RTGO 98-13

		Age Group:		Adults Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Prior Surgery is Allowed Prior Radiation is Not Allowed Prior Chemotherapy is Not Allowed

		Last Updated:		05/01/2007

		Tumor Types:		Anaplastic Astrocytoma Mixed Glioma Oligodendroglioma High Grade


		Comments:		Patients are randomized between Radiation and Temozolomide vs Radiation and BCNU

		Treatment Type:		Chemotherapy Radiation

		Contact:		Toni Kay Mangskau-MN Clinical Trials Referral Coordinator Mayo Clinic Cancer Center - MN 200 First Street SW Rochester, MN 55905 USA Phone: (507)538-7623 Fax: E-mail: mangskau.toni@mayo.edu Website: www.mayoclinic.org/cancer-treatment/

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By